1. Home
  2. BLRX vs BLIN Comparison

BLRX vs BLIN Comparison

Compare BLRX & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • BLIN
  • Stock Information
  • Founded
  • BLRX 2003
  • BLIN 2000
  • Country
  • BLRX Israel
  • BLIN United States
  • Employees
  • BLRX N/A
  • BLIN N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • BLIN EDP Services
  • Sector
  • BLRX Health Care
  • BLIN Technology
  • Exchange
  • BLRX Nasdaq
  • BLIN Nasdaq
  • Market Cap
  • BLRX 17.2M
  • BLIN 16.5M
  • IPO Year
  • BLRX 2011
  • BLIN 2007
  • Fundamental
  • Price
  • BLRX $3.81
  • BLIN $1.29
  • Analyst Decision
  • BLRX Strong Buy
  • BLIN Strong Buy
  • Analyst Count
  • BLRX 2
  • BLIN 1
  • Target Price
  • BLRX $19.00
  • BLIN $4.62
  • AVG Volume (30 Days)
  • BLRX 32.7K
  • BLIN 27.9K
  • Earning Date
  • BLRX 08-14-2025
  • BLIN 08-14-2025
  • Dividend Yield
  • BLRX N/A
  • BLIN N/A
  • EPS Growth
  • BLRX N/A
  • BLIN N/A
  • EPS
  • BLRX N/A
  • BLIN N/A
  • Revenue
  • BLRX $17,251,000.00
  • BLIN $15,375,000.00
  • Revenue This Year
  • BLRX N/A
  • BLIN $2.45
  • Revenue Next Year
  • BLRX N/A
  • BLIN $16.36
  • P/E Ratio
  • BLRX N/A
  • BLIN N/A
  • Revenue Growth
  • BLRX 1.19
  • BLIN 0.54
  • 52 Week Low
  • BLRX $2.30
  • BLIN $1.05
  • 52 Week High
  • BLRX $26.80
  • BLIN $2.80
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 49.18
  • BLIN 39.30
  • Support Level
  • BLRX $3.68
  • BLIN $1.33
  • Resistance Level
  • BLRX $4.11
  • BLIN $1.40
  • Average True Range (ATR)
  • BLRX 0.24
  • BLIN 0.05
  • MACD
  • BLRX 0.02
  • BLIN -0.00
  • Stochastic Oscillator
  • BLRX 41.50
  • BLIN 0.00

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: